Cizumab (Bevacizumab) | Used for Cancer Treatment and Related Conditions
Cizumab contains bevacizumab, an active ingredient used as part of treatment for certain types of cancer and other specific conditions. It works by blocking vascular endothelial growth factor (VEGF), a protein that promotes the formation of new blood vessels. By reducing the growth of blood vessels that supply abnormal tissues, bevacizumab can help slow the growth and spread of certain cancers.
Product Overview
What Is Cizumab Injection?
Cizumab Injection contains bevacizumab, an active ingredient used as part of treatment for certain types of cancer and other specific medical conditions. Bevacizumab belongs to a group of medicines known as angiogenesis inhibitors. It works by targeting vascular endothelial growth factor (VEGF), which plays an important role in the formation of new blood vessels.
How Does Cizumab Injection Work?
Bevacizumab binds to VEGF and reduces its activity, which can limit the formation of new blood vessels that supply abnormal tissues. By reducing this blood supply, bevacizumab may help slow the growth and progression of certain cancers. It is commonly used in combination with other cancer treatments depending on the condition being treated.
| Product Information | Details |
| Product Name | Cizumab Injection |
| Active Ingredient | Bevacizumab |
| Product Type | Anti-VEGF Medicine |
| Dosage Form | Injection |
| Main Uses | Treatment of certain cancers and related conditions |
| Route | Intravenous |
What Is Cizumab Injection Used For?
Cizumab Injection is used as part of treatment for certain cancers, depending on the patient's condition and treatment plan. It may be used alone in specific situations or in combination with other anticancer medicines.
Cancer Treatment
Bevacizumab may be used in the treatment of certain cancers by inhibiting the formation of new blood vessels that can support tumor growth. Its use depends on the type and stage of cancer and the overall treatment approach.
Reducing Tumor Blood Supply
Cizumab works by blocking VEGF, a protein involved in blood-vessel formation. Reducing VEGF activity can limit the development of blood vessels that supply abnormal cells.
Combination Cancer Therapy
Bevacizumab is often used together with other anticancer treatments for selected conditions. The specific combination and treatment schedule depend on the type of cancer and the individual's clinical situation.
Supporting Disease Management
By interfering with processes involved in abnormal blood-vessel formation, bevacizumab can form part of a broader treatment strategy for certain cancers and other conditions where VEGF plays a role.
Precaution
High Blood Pressure
Cizumab may increase blood pressure during treatment. Blood pressure should be monitored regularly, particularly in people with a history of hypertension. Inform a healthcare professional if severe headache, dizziness, or other symptoms associated with high blood pressure occur.
Bleeding Risk
Bevacizumab may increase the risk of bleeding. Inform a healthcare professional about any unusual bruising, nosebleeds, blood in the urine or stool, or other unexpected bleeding.
Surgery and Wound Healing
Bevacizumab can affect wound healing. Inform the treating healthcare professional about any planned surgery or recent surgical procedure. Treatment may need to be managed around the time of surgery.
Kidney-Related Conditions
Bevacizumab may cause protein to appear in the urine and, in some cases, affect kidney function. Appropriate urine and kidney-function monitoring may be recommended during treatment.
Blood Clots
Treatment with bevacizumab may be associated with an increased risk of blood clots in some people. Inform a healthcare professional about symptoms such as sudden chest discomfort, breathing difficulty, or swelling and pain in a limb.
Gastrointestinal Problems
Rarely, bevacizumab may cause serious gastrointestinal complications, including perforation. Report severe or persistent abdominal pain, vomiting, fever, or other unusual abdominal symptoms promptly.
Pregnancy
Bevacizumab may cause harm to a developing fetus. If you are pregnant, planning pregnancy, or could become pregnant, discuss the appropriate precautions with your healthcare professional before treatment.
Breastfeeding
Breastfeeding may not be recommended during treatment with bevacizumab and for a period after the final dose. Discuss breastfeeding plans with a healthcare professional.
Monitoring During Treatment
Regular medical monitoring may be required during Cizumab treatment, including checks of blood pressure, urine protein, blood counts, and other parameters depending on the treatment plan. Report unusual or severe symptoms promptly.
Usage
Follow the Recommended Treatment Schedule
Cizumab Injection should be administered according to the treatment schedule determined by the treating healthcare professional. The dose and frequency may vary depending on the condition being treated and the overall treatment plan.
Administer Through Intravenous Infusion
Cizumab is administered by intravenous infusion under appropriate medical supervision. It should not be self-administered or injected without proper medical guidance.
Follow the Infusion Instructions
The infusion should be given according to the recommended rate and protocol. The initial infusion may be administered more slowly, with subsequent infusions adjusted according to individual tolerance and clinical guidance.
Regular Treatment Monitoring
Regular monitoring may be required during treatment, including blood pressure checks, urine protein assessment, and other tests as considered appropriate by the treating healthcare professional.
Inform About Surgery
Tell the treating healthcare professional about any planned or recent surgery before receiving Cizumab, as bevacizumab may affect wound healing.
Do Not Change or Stop Treatment Without Guidance
Do not change the dose, skip scheduled treatments, or discontinue Cizumab without discussing it with the treating healthcare professional.
Uses
Cancer Treatment
Cizumab Injection is used as part of treatment for certain types of cancer. Its specific use depends on the type of cancer and the overall treatment plan.
Colorectal Cancer
Bevacizumab may be used in combination with other anticancer medicines for certain cases of metastatic colorectal cancer.
Lung Cancer
Bevacizumab may be used as part of treatment for selected forms of advanced or metastatic non-small cell lung cancer.
Kidney Cancer
Bevacizumab may be combined with other anticancer medicines for certain cases of advanced or metastatic kidney cancer.
Ovarian and Related Cancers
Bevacizumab may be used in the treatment of certain ovarian, fallopian tube, or primary peritoneal cancers, depending on the clinical situation.
Supporting Long-Term Disease Management
By blocking VEGF and reducing the formation of new blood vessels that can support abnormal tissue growth, bevacizumab may form part of a broader treatment strategy for selected cancers.
Side Effects
High Blood Pressure
Cizumab may increase blood pressure in some people during treatment. Regular blood pressure monitoring may be recommended, especially during ongoing therapy.
Weakness and Tiredness
Some people may experience tiredness, weakness, or reduced energy while receiving bevacizumab. If these symptoms become persistent or troublesome, seek appropriate medical advice.
Headache
Headache may occur during treatment with Cizumab. Inform a healthcare professional if headaches are severe, persistent, or associated with other unusual symptoms.
Nausea
Some people may experience nausea during treatment. Taking appropriate supportive measures as advised by a healthcare professional may help manage this symptom.
Bleeding
Bevacizumab can increase the risk of bleeding in some patients. Report unusual bruising, persistent bleeding, blood in the stool or urine, or coughing up blood promptly.
Mouth Sores
Soreness or irritation inside the mouth may occur during treatment. Maintaining good oral hygiene and informing a healthcare professional about persistent mouth problems may be helpful.
Protein in Urine
Cizumab may cause protein to appear in the urine. Urine tests may be performed during treatment to monitor kidney-related effects.
Delayed Wound Healing
Bevacizumab may interfere with normal wound healing. Inform the treating healthcare professional about recent or planned surgery or if a wound is healing slowly.
Serious or Unusual Symptoms
Rare but serious reactions can occur with bevacizumab, including severe bleeding, blood clots, gastrointestinal perforation, or significant changes in blood pressure. Seek immediate medical attention if severe or unusual symptoms develop.
FAQs
What Is Cizumab Injection?
Cizumab Injection contains bevacizumab, an active ingredient that works by blocking vascular endothelial growth factor (VEGF). It is used as part of treatment for certain types of cancer and other specific conditions.
What Is Cizumab Injection Used For?
Cizumab is used as part of treatment for certain cancers, including selected colorectal, lung, kidney, ovarian, and related cancers. Its specific use depends on the condition and overall treatment plan.
How Does Cizumab Injection Work?
Bevacizumab blocks VEGF, a protein involved in the formation of new blood vessels. By reducing VEGF activity, it can limit the development of blood vessels that supply abnormal tissues.
How Is Cizumab Injection Given?
Cizumab is administered through an intravenous infusion by a qualified healthcare professional. The dose and infusion schedule depend on the condition being treated and the individual treatment plan.
Can Cizumab Cause High Blood Pressure?
Yes, increased blood pressure can occur during bevacizumab treatment. Blood pressure may be monitored regularly, and significant increases should be reported to the treating healthcare professional.
Can Cizumab Increase the Risk of Bleeding?
Yes, bevacizumab may increase the risk of bleeding in some people. Report unusual bruising, persistent nosebleeds, blood in the urine or stool, or other unexpected bleeding promptly.
Does Cizumab Affect Wound Healing?
Bevacizumab may interfere with normal wound healing. Inform the treating healthcare professional about any planned or recent surgery before receiving Cizumab.
What Should I Do If I Develop Severe or Unusual Symptoms?
Seek prompt medical attention if you experience severe abdominal pain, significant bleeding, sudden breathing difficulty, chest discomfort, severe headache, or other serious or unusual symptoms during treatment.
Interactions
Other Cancer Treatments
Cizumab may be used together with other anticancer medicines as part of a treatment plan. The combination may affect the risk of certain adverse reactions, so the treating healthcare professional should review all ongoing cancer treatments.
Medicines That Increase Bleeding Risk
Medicines that affect blood clotting or platelet function may increase the risk of bleeding when used with bevacizumab. Inform your healthcare professional about medicines such as anticoagulants or antiplatelet agents.
Blood Pressure Medicines
Bevacizumab can increase blood pressure in some people. If you are taking medicines for hypertension, your blood pressure may require closer monitoring during treatment.
Medicines Affecting Kidney Function
Certain medicines may affect kidney function, while bevacizumab can cause protein to appear in the urine. Inform your healthcare professional about medicines you regularly use so appropriate monitoring can be considered.
Other Medicines and Treatments
Tell your healthcare professional about all prescription medicines, over-the-counter products, vitamins, and supplements you use. This helps identify potential interactions and supports appropriate treatment planning with Cizumab.
Surgery and Other Procedures
Bevacizumab may affect wound healing and may require special consideration around surgical procedures. Inform the treating healthcare professional about any planned or recent surgery or invasive procedure.
Live Vaccines and Immunisations
Inform your healthcare professional about any planned vaccinations during treatment. The suitability and timing of particular vaccines may depend on your overall treatment plan and health condition.
| Manufacturer | : | Intas Pharmaceuticals |
| Equivalent Brand | : | Avastin |
| Generic Search | : | Bevacizumab |























